CryoPort Quarterly Balance Sheet
NASDAQ: CYRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CryoPort financial position
As of Jun 30, 2026, CryoPort reported total assets of $756.2 million, down 2.3% from a year earlier against total liabilities of $265.5 million. Shareholders' equity stood at $490.7 million, or 64.9% of assets. The company held $269.3 million in cash and equivalents against $985,000 of debt, a net cash position of $268.3 million.
The current ratio (current assets divided by current liabilities) was 2.08, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.00.
Summary generated from market data by MetaCap's automated system. Methodology
CryoPort balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 269.27M | 272.91M | 250.49M | 255.81M | 243.42M | 36.10M | 34.14M | 31.37M | 34.18M | 39.29M | 35.19M | 59.47M |
| Short-Term Investments | 127.43M | 130.72M | 160.71M | 165.50M | 182.56M | 207.93M | 216.46M | 228.00M | 380.68M | 398.88M | 410.41M | 406.39M |
| Receivables | 36.45M | 39.00M | 33.36M | 34.91M | 33.41M | 28.37M | 25.30M | 43.46M | 40.16M | 41.25M | 42.07M | 42.63M |
| Inventory | 21.51M | 21.75M | 23.19M | 23.33M | 23.04M | 23.34M | 21.48M | 23.55M | 23.61M | 25.02M | 26.21M | 29.10M |
| Total Current Assets | 460.20M | 470.54M | 476.17M | 484.84M | 489.49M | 411.28M | 341.57M | 350.34M | 501.99M | 525.70M | 535.11M | 549.14M |
| Property, Plant & Equipment | 94.52M | 89.81M | 85.45M | 83.23M | 81.56M | 80.48M | 80.01M | 88.28M | 86.65M | 86.01M | 84.86M | 74.52M |
| Goodwill | 22.07M | 22.14M | 22.40M | 22.41M | 18.71M | 20.96M | 20.57M | 54.06M | 52.38M | 107.59M | 76.39M | 148.95M |
| Intangible Assets | 135.99M | 138.72M | 138.08M | 141.25M | 143.59M | 145.41M | 147.93M | 175.81M | 178.39M | 190.09M | 194.38M | 192.96M |
| Total Assets | 756.20M | 763.61M | 764.99M | 774.33M | 773.93M | 699.84M | 703.49M | 701.76M | 852.34M | 942.85M | 957.74M | 1.00B |
| Accounts Payable | 16.25M | 15.94M | 15.28M | 13.88M | 14.76M | 13.44M | 15.89M | 25.19M | 24.80M | 27.38M | 27.00M | 27.88M |
| Total Current Liabilities | 221.04M | 224.87M | 219.02M | 30.75M | 30.15M | 74.03M | 64.56M | 61.44M | 59.88M | 48.98M | 45.61M | 44.91M |
| Long-Term Debt | 985.00K | 1.03M | 1.09M | 1.29M | 1.33M | 1.12M | 1.11M | 1.24M | 1.26M | 1.30M | 1.33M | 307.00K |
| Total Liabilities | 265.50M | 268.62M | 262.35M | 261.06M | 258.54M | 301.03M | 301.59M | 283.19M | 452.25M | 470.66M | 468.72M | 463.13M |
| Shareholders' Equity | 490.70M | 494.99M | 502.64M | 513.27M | 519.08M | 398.81M | 401.90M | 418.57M | 400.10M | 472.19M | 489.02M | 537.53M |
| Retained Earnings | -707.68M | -699.43M | -688.88M | -675.24M | -668.24M | -769.16M | -757.17M | -738.50M | -739.30M | -661.31M | -642.42M | -580.03M |
| Total Debt | 985.00K | 1.03M | 1.09M | 1.29M | 1.33M | 1.12M | 1.11M | 1.24M | 1.26M | 1.30M | 1.33M | 307.00K |
| Net Cash (Debt) | 395.71M | 402.61M | 410.12M | 420.02M | 424.65M | 242.91M | 249.48M | 258.13M | 413.61M | 436.87M | 444.27M | 465.56M |
| Shares Outstanding | 50.65M | 50.20M | 49.85M | 50.07M | 50.28M | 50.14M | 49.91M | 49.43M | 49.41M | 49.26M | 48.97M | 48.96M |
This table shows 12 quarterly periods of CryoPort's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow CYRX's reporting calendar. What is a balance sheet?